Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:589-591
doi: 10.1161/01.RES.0000095382.50153.7D
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roden, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roden, D. M.
Related Collections
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Heart failure - basic studies
Right arrow Arrhythmias, clinical electrophysiology, drugs
(Circulation Research. 2003;93:589.)
© 2003 American Heart Association, Inc.


Editorials

A Surprising New Arrhythmia Mechanism in Heart Failure

Dan M. Roden

From the Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Dan M. Roden, MD, Professor of Medicine and Pharmacology, Director, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 532 Medical Research Building I, Nashville, TN 37232. E-mail dan.roden@vanderbilt.edu


Key Words: arrhythmia • heart failure • long QT


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Heart failure is the most common discharge diagnosis in the United States, with a prognosis worse than many cancers.1 Patients with heart failure die for two reasons: advanced circulatory insufficiency or sudden death.2 We know that continuous online monitoring of cardiac rhythm from patients with advanced heart failure is inevitably abnormal and often shows long runs of irregular and/or polymorphic ventricular tachycardia. Unlike patients with ventricular tachycardia due to healed myocardial infarction, those with heart failure rarely have ventricular tachycardia inducible by programmed stimulation, and when it is, its prognostic importance is uncertain. Therapy with conventional antiarrhythmics is no more successful in patients with heart failure than in those with serious ventricular arrhythmias due to healed infarction.

Arrhythmias, Disordered [Ca2+]i Homeostasis, and K+ Current Downregulation in Heart Failure

Given the huge public health impact of the problem and the failure of current pharmacological therapies, one obvious way forward in attacking the problem of sudden death in heart failure is to understand the basic molecular mechanisms underlying arrhythmia susceptibility in this setting. The disordered contractility that characterizes heart failure naturally suggests abnormal intracellular calcium homeostasis, a well-recognized feature of the heart failure phenotype,3,4 as a candidate arrhythmia mechanism, and experimental studies support this idea. Pogwizd and colleagues have used three-dimensional activation mapping in rabbits with volume-overload heart failure to identify focal triggers and repetitive focal activity as a major mechanism underlying VT in this model,5 behaviors that are highly reminiscent of afterdepolarization-related triggering due to intracellular calcium overload. Indeed, their further studies indicated that heart failure–related upregulation of the sodium-calcium exchanger, in . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Weber dos Santos, A. Nygren, F. Otaviano Campos, H. Koch, and W. R. Giles
Experimental and theoretical ventricular electrograms and their relation to electrophysiological gradients in the adult rat heart
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1521 - H1534.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S.-X. Zhou, J. Lei, C. Fang, Y.-L. Zhang, and J.-F. Wang
Ventricular electrophysiology in congestive heart failure and its correlation with heart rate variability and baroreflex sensitivity: a canine model study
Europace, February 1, 2009; 11(2): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
N. S. Ghais, Y. Zhang, A. A. Grace, and C. L.-H. Huang
Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts
Exp Physiol, February 1, 2009; 94(2): 240 - 254.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
D. Stilli, R. Berni, L. Bocchi, M. Zaniboni, F. Cacciani, A. Sgoifo, and E. Musso
Vulnerability to ventricular arrhthmias and heterogeneity of action potential duration in normal rats
Exp Physiol, July 1, 2004; 89(4): 387 - 396.
[Abstract] [Full Text] [PDF]